LAPIX Therapeutics, Inc. (“LAPIX”), a clinical-stage biopharmaceutical company developing first-in-class, orally delivered immune-tolerance-restoring therapies, announced today that the first patient ...

Peptinov today announced the publication of the Phase 1 clinical results for PPV-06, its first-in-class active immunotherapy targeting IL-6, in the peer-reviewed journal Nature Communications. The ...

To date, ETX101 has shown a favorable safety profile and has been well-tolerated across all four dose levels with no treatment-related serious adverse events (n=19). The most common treatment-related ...

Iberdomide and mezigdomide are currently being evaluated for the treatment of patients with multiple myeloma in a number of trials, with results so far showing activity in relapsed or refractory ...

A patient controls a robotic dog during the BCI clinical trail. Photo: Courtesy of the CEBSIT. The Global Times learned on ...

It has been almost 75 years since the first North Korean People’s Army crossed the 38th parallel, beginning a war that still ...

Mars looks quiet today, but new research suggests the planet’s surface still carries the rhythm of a vanished companion.

Engineers designing RF systems at millimeter wave frequencies face exponentially increasing challenges as losses compound, parasitics dominate, and system integration becomes critical.

A U.S. lawmaker has proposed phasing out Chinese-made sensors in self-driving cars and critical infrastructure amid warnings they could be hacked and disabled from space during a conflict, crippling ...

Milestone Pharmaceuticals announced the FDA approval of prescription etripamil nasal spray for the treatment of acute ...

Over the past decades, engineers have introduced numerous technologies that rely on light and its underlying characteristics. These include photonic and quantum systems that could advance imaging, ...